Mucuna pruriens attenuates haloperidol-induced orofacial dyskinesia in rats

Nat Prod Res. 2011 Apr;25(8):764-71. doi: 10.1080/14786410902819087. Epub 2010 Jul 13.

Abstract

Neuroleptic-induced tardive dyskinesia (TD) is a motor disorder of the orofacial region resulting from chronic neuroleptic treatment. The agents improving dopaminergic transmission improve TD. Mucuna pruriens seed contains levodopa and amino acids. The effect of methanolic extract of M. pruriens seeds (MEMP) was studied on haloperidol-induced TD, alongside the changes in lipid peroxidation, reduced glutathione, superoxide dismutase (SOD) and catalase levels. The effect of MEMP was also evaluated in terms of the generation of hydroxyl and 1,1-diphenyl,2-picrylhydrazyl (DPPH) radical. MEMP (100 and 200 mg kg⁻¹) inhibited haloperidol-induced vacuous chewing movements, orofacial bursts and biochemical changes. MEMP also inhibited hydroxyl radical generation and DPPH. The results of the present study suggest that MEMP by virtue of its free radical scavenging activity prevents neuroleptic-induced TD.

MeSH terms

  • Akathisia, Drug-Induced / drug therapy*
  • Animals
  • Antioxidants / therapeutic use
  • Free Radicals / metabolism
  • Haloperidol / toxicity*
  • Male
  • Mucuna / chemistry*
  • Plant Extracts / chemistry
  • Plant Extracts / therapeutic use*
  • Rats
  • Rats, Wistar
  • Vitamin E / therapeutic use

Substances

  • Antioxidants
  • Free Radicals
  • Plant Extracts
  • Vitamin E
  • Haloperidol